Safety and Efficacy of Treg Cell in the Treatment of GVHD
NCT06411184
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
GVHD
Interventions
DRUG:
Regulator T Cells
Sponsor
Xuzhou Medical University